Phosphorylation of human phospholipase A1 DDHD1 at newly identified phosphosites affects its subcellular localization

Autor: Atsushi Yamashita, Yoko Nemoto-Sasaki, Seisuke Arai, Saori Oka, Ikuo Wada, Naoki Matsumoto
Rok vydání: 2021
Předmět:
IB
immunoblot

0301 basic medicine
environment and public health
Biochemistry
IMAC
immobilized metal affinity chromatography

PA
phosphatidic acid

Phosphorylation
LPI
lysophosphatidylinositol

CDK
cyclin-dependent kinase

biology
Kinase
Chemistry
IP
immunoprecipitation

cyclin-dependent kinase (CDK)
GSK-3
glycogen synthase kinase-3

Cell biology
Phos-tag
Casein kinase 1
Casein kinase 2
λPP
lambda protein phosphatase

LPA
lysophosphatidic acid

Research Article
inorganic chemicals
Hyperphosphorylation
Glycerophospholipids
03 medical and health sciences
Cyclin-dependent kinase
CDC2 Protein Kinase
Humans
Molecular Biology
MALDI-TOF MS
matrix-assisted laser desorption ionization time-of-flight mass spectrometry

Cyclin-dependent kinase 1
HSP
hereditary spastic paraplegia

030102 biochemistry & molecular biology
Spastic Paraplegia
Hereditary

Cyclin-dependent kinase 5
Cell Membrane
DDHD domain containing 1 (DDHD1)
Cell Biology
Phospholipases A1
CK2
casein kinase 2

enzymes and coenzymes (carbohydrates)
HEK293 Cells
030104 developmental biology
Spectrometry
Mass
Matrix-Assisted Laser Desorption-Ionization

phospholipase A1 (PLA1)
biology.protein
bacteria
Cyclin A2
hereditary spastic paraplegia (HSP)
Zdroj: The Journal of Biological Chemistry
ISSN: 0021-9258
DOI: 10.1016/j.jbc.2021.100851
Popis: Phospholipase A1 (PLA1) hydrolyzes the fatty acids of glycerophospholipids, which are structural components of the cellular membrane. Genetic mutations in DDHD1, an intracellular PLA1, result in hereditary spastic paraplegia (HSP) in humans. However, the regulation of DDHD1 activity has not yet been elucidated in detail. In the present study, we examined the phosphorylation of DDHD1 and identified the responsible protein kinases. We performed MALDI-TOF MS/MS analysis and Phos-tag SDS-PAGE in alanine-substitution mutants in HEK293 cells and revealed multiple phosphorylation sites in human DDHD1, primarily Ser8, Ser11, Ser723, and Ser727. The treatment of cells with a protein phosphatase inhibitor induced the hyperphosphorylation of DDHD1, suggesting that multisite phosphorylation occurred not only at these major, but also at minor sites. Site-specific kinase-substrate prediction algorithms and in vitro kinase analyses indicated that cyclin-dependent kinase CDK1/cyclin A2 phosphorylated Ser8, Ser11, and Ser727 in DDHD1 with a preference for Ser11 and that CDK5/p35 also phosphorylated Ser11 and Ser727 with a preference for Ser11. In addition, casein kinase CK2α1 was found to phosphorylate Ser104, although this was not a major phosphorylation site in cultivated HEK293 cells. The evaluation of the effects of phosphorylation revealed that the phosphorylation mimic mutants S11/727E exhibit only 20% reduction in PLA1 activity. However, the phosphorylation mimics were mainly localized to focal adhesions, whereas the phosphorylation-resistant mutants S11/727A were not. This suggested that phosphorylation alters the subcellular localization of DDHD1 without greatly affecting its PLA1 activity.
Databáze: OpenAIRE